T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Alcon
ALC
|
+$2.23B |
| 2 |
TSS
Total System Services, Inc.
TSS
|
+$1.45B |
| 3 |
Linde
LIN
|
+$1.44B |
| 4 |
American International
AIG
|
+$1.43B |
| 5 |
Marvell Technology
MRVL
|
+$1.31B |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$2.31B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
RHT
Red Hat Inc
RHT
|
+$1.58B |
| 4 |
Eli Lilly
LLY
|
+$1.54B |
| 5 |
Booking.com
BKNG
|
+$1.17B |
Sector Composition
| 1 | Technology | 18.89% |
| 2 | Healthcare | 16.97% |
| 3 | Financials | 13.8% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
Manhattan Associates
MANH
$13.2B
| $44.4M | 0.01% |
640,807
-2,366
| -0.4% | -$164K |
|
927
Grifois
GRFS
$6.78B
| $44.2M | 0.01% |
2,096,661
-2,540,837
| -55% | -$53.6M |
|
|
GTHX
928
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $43.7M | 0.01% |
1,424,609
-65,558
| -4% | -$2.01M |
|
929
Virtus Investment Partners
VRTS
$1.35B
| $43.6M | 0.01% |
406,120
-10,759
| -3% | -$1.16M |
|
930
Generac Holdings
GNRC
$11B
| $43.5M | 0.01% |
627,076
-7,367
| -1% | -$511K |
|
931
Kirby Corp
KEX
$4.88B
| $43.5M | 0.01% |
550,943
-4,956
| -0.9% | -$392K |
|
932
Adaptive Biotechnologies
ADPT
$2.02B
| $43.5M | 0.01% |
+900,000
| New | +$43.5M |
|
933
Hartford Financial Services
HIG
$37.4B
| $43.5M | 0.01% |
779,902
+89,832
| +13% | +$5.01M |
|
934
Fluor
FLR
$6.66B
| $43.3M | 0.01% |
1,284,676
+720,654
| +128% | +$24.3M |
|
|
DHR.PRA
935
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $43.2M | 0.01% |
39,210
| – | – |
|
936
Middleby
MIDD
$7.02B
| $43M | 0.01% |
316,584
-198,932
| -39% | -$27M |
|
|
GNMK
937
DELISTED
GenMark Diagnostics, Inc
GNMK
| $42.8M | 0.01% |
6,589,491
-1,101,642
| -14% | -$7.15M |
|
938
Saic
SAIC
$4.92B
| $42.7M | 0.01% |
493,744
-3,411
| -0.7% | -$295K |
|
|
CDR
939
DELISTED
Cedar Realty Trust, Inc
CDR
| $42.5M | 0.01% |
2,431,340
-16,337
| -0.7% | -$286K |
|
940
Ormat Technologies
ORA
$5.55B
| $42.3M | 0.01% |
667,565
-5,640
| -0.8% | -$358K |
|
941
Team
TISI
$88.2M
| $42.2M | 0.01% |
275,135
+860
| +0.3% | +$132K |
|
942
Murphy USA
MUSA
$7.56B
| $41.7M | 0.01% |
495,893
-4,074
| -0.8% | -$342K |
|
943
Cencora
COR
$59.3B
| $41.6M | 0.01% |
487,551
+200,638
| +70% | +$17.1M |
|
944
Celanese
CE
$5.07B
| $41.5M | 0.01% |
385,073
-12,920
| -3% | -$1.39M |
|
|
ANSS
945
DELISTED
Ansys
ANSS
| $41.3M | 0.01% |
201,630
+19
| +0% | +$3.89K |
|
|
FBMS
946
DELISTED
The First Bancshares, Inc.
FBMS
| $41.2M | 0.01% |
1,358,252
+80,962
| +6% | +$2.46M |
|
947
Parker-Hannifin
PH
$96.9B
| $41.1M | 0.01% |
241,814
-89
| -0% | -$15.1K |
|
948
Encompass Health
EHC
$12.7B
| $41.1M | 0.01% |
815,202
-2,987
| -0.4% | -$151K |
|
|
CY
949
DELISTED
Cypress Semiconductor
CY
| $40.9M | 0.01% |
1,838,581
-977,135
| -35% | -$21.7M |
|
|
QTS
950
DELISTED
QTS REALTY TRUST, INC.
QTS
| $40.9M | 0.01% |
884,682
+84,905
| +11% | +$3.92M |
|